Breaking News

U.S. Says 72-Hour Cease-Fire Agreed in Gaza, to Start Tomorrow
Tweet TWEET

Galena Biopharma to Present at the Rodman & Renshaw Annual Global Investment Conference

Galena Biopharma to Present at the Rodman & Renshaw Annual Global Investment
Conference

PORTLAND, Ore., Sept. 4, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma
(Nasdaq:GALE), a biopharmaceutical company commercializing and developing
innovative, targeted oncology treatments that address major unmet medical
needs to advance cancer care, today announced that Mark J. Ahn, Ph.D.,
President & Chief Executive Officer, will present a corporate update at the
Rodman & Renshaw Annual Global Investment Conference. The presentation will
take place on Monday, September 9, 2013 at 10:25 a.m. ET at the Millennium
Broadway Hotel in New York, NY.

The presentation will be webcast and available on the Investors section of the
Company's website at www.galenabiopharma.com.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based
biopharmaceutical company commercializing and developing innovative, targeted
oncology treatments that address major unmet medical needs to advance cancer
care. For more information please visit us at www.galenabiopharma.com.

CONTACT: Remy Bernarda
         Senior Director, Communications
         (503) 405-8258
         rbernarda@galenabiopharma.com

Galena Biopharma, Inc.